Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Chronic Spontaneous Urticaria
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
Article
Statins, fibrates won't help
New York - Cholesterol-lowering statins and fibrates apparently aren't linked to a reduced risk of melanoma, researchers report.
New York - Cholesterol-lowering statins and fibrates apparently aren't linked to a reduced risk of melanoma, researchers report.
Investigators came to the conclusion after reviewing data from 20 randomized controlled trials involving almost 71,000 participants, according to the Nov. 1 issue of the Journal of the National Cancer Institute.
Twelve trials were for statins and eight for fibrates, Reuters reports.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Related Videos
Related Content
